Need help? Order a test
News

Cancer gene testing could save millions of lives worldwide

Population-based screening for the BRCA genes that cause ovarian and breast cancer could save millions of lives a year, scientists have found. A new study, published in the journal Cancer, found that population-based genetic testing for BRCA 1 and BRCA 2 genes – where every woman over 30, regardless of risk-factor is screened – was […]

Read more
News

Unlocking the role of genes in hereditary breast cancer

Mutations in genes only appear in 20% of women offered genetic testing for breast cancer, a new study by University of Melbourne researchers. Previously scientists believed that mutations in known breast cancer genes such as BRCA1 and BRCA2 caused cancer, but in a pioneering study, they were only present in 1 in 5 cases. Instead, […]

Read more
News

Personalised cancer treatment improves patient outcomes

Patients with advanced cancer were more likely to survive for longer or experience longer periods without disease progression if they received personalised cancer therapy, researchers at the University of California San Diego School of Medicine have found. In a recent trial, three-year survival for cancer patients receiving personalised cancer treatments was 55%, compared to 25% […]

Read more
News

Cancer diagnosis delays could cost thousands of lives

Delays to cancer diagnosis caused by COVID-19 could be responsible for thousands of avoidable deaths in the UK, a new report study published in The Lancet has found. In a ground-breaking new population-based modelling study, a London-based research team has attempted to calculate the impact of the coronavirus pandemic on cancer diagnosis and treatment outcomes. […]

Read more
News

Scientists identify new biomarker for cancer diagnosis

Scientists have identified tiny packages of materials released by tumours, called EVPs (extracellular vesicles and particles) that could be a potential biomarker for detecting several types of cancer at an early stage. In a recent study, published in the prestigious Cell journal, a US-based team have identified an exciting new biomarker that could lead to […]

Read more
News

Nutrition as a ‘precision medicine’ in cancer treatment

We know that a healthy diet and good nutrition might contribute in reduction of risk of certain cancers. Diets that are high in plant foods – such as fruit, vegetables, wholegrains and beans – may protect against certain cancers. For example, diets with a high proportion of these fibre-rich foods can protect against bowel cancer. […]

Read more
News

Liquid biopsy blood tests could be used to diagnose brain tumours

Results of a promising trial in people with brain tumours suggests that a specific blood test could be used for more accurate diagnosis, without the need for invasive procedures. The blood test based on circulating-tumour DNA (ctDNA) has been found to accurately classify different types of brain tumours and could allow for better treatment planning […]

Read more
News

Simple blood tests can be used to look for resistance to chemotherapy

When it comes to treating cancer, there’s good news and bad news. Part of the good news is that there are many effective medicines, known as chemotherapies, that can treat cancer and improve survival. The not so good news is that some cancers that initially respond to chemotherapy can become resistant to treatment. This means […]

Read more
News

Circulating tumour cells may predict breast cancer outcomes

Breast cancer is the second most common cancer worldwide and there were over 2 million new cases in 2018, according to the World Cancer Research Fund. So there is great research interest in understanding more about what determines how likely people with breast cancer are to survive, and to respond to treatment. Researchers at Cleveland […]

Read more
News

Liquid biopsies shed light on cancer drug resistance

It is not uncommon for people with cancer to have treatment with a drug that is initially effective at shrinking their tumour, only for it to grow back as the cancer cells in the tumour evolve and become resistant to the drugs. It is estimated that drug resistance and the resulting ineffectiveness of treatments are […]

Read more
News

Multi-cancer blood test can detect 26 cancers

In the first study of its kind, researchers have used a simple blood test to safely detect multiple cancers in nearly 10,000 women with undiagnosed cancer. In some cases, women who took the blood test were able to have treatment to potentially cure the cancer. The researchers at the Johns Hopkins Kimmel Cancer Center in […]

Read more
News

RGCC Investigates Potential Treatments and Tests for COVID-19

As the world tries to cope with the rise in cases of covid-19 during the coronavirus pandemic, drug companies are racing to develop treatments that could reduce the number of deaths from the illness. This includes the specialist medical genetic testing company RGCC, which has turned its expertise and technology in the diagnosis and treatment […]

Read more

Global Presence

RGCC operates in 23 countries across the world, with bases in all five continents.

Find out more